BioSpace News Archive

The leader in women’s and family health expands into payments with the launch of Maven Wallet

Canon Medical Systems USA, Inc. has received 510(k) clearance for the Aquilion ONE / PRISM Edition, enabling Deep Learning Spectral capabilities that allow for more routine spectral imaging.

Meridian Bioscience, Inc. (NASDAQ: VIVO) and Exalenz Bioscience Ltd. (TASE: EXEN) announced today that the two companies have entered into a definitive agreement for Meridian to acquire Exalenz for ₪6.10 per share in cash with an implied transaction value of approximately $49 million.

SAN DIEGO , Feb. 19, 2020 /PRNewswire/ -- Mirati Therapeutics, Inc. (Nasdaq: MRTX), a clinical stage targeted oncology company, today announced the grants of inducement non-qualified stock options to purchase an aggregate of 26,712 shares of common stock and an aggregate of 16,659 restricted stock units (“RSUs”) to three new employees. Each stock option has an exercise pric

Feb. 19, 2020 13:35 UTC ORP-101 Currently in Phase 2 Study for Treatment of Irritable Bowel Syndrome with Diarrhea SAN FRANCISCO--( BUSINESS WIRE )-- OrphoMed, Inc., a clinical-stage biopharmaceutical company, today announced the presentation at Digestive Disease Week ® (DDW) of Phase 1 data for its lead candidate ORP-101, being developed for the treatment of irritable bowel syndrome with diarrhea. Anthony J. Lembo, M.D., Director of the GI Motility and Functional Bowe

Feb. 19, 2020 13:30 UTC Viz RECRUIT offers New Algorithms for ICH, Aneurysm Detection and Ischemic Core Volumes, together with improved imaging sharing and collaboration software SAN FRANCISCO--( BUSINESS WIRE )-- Viz.ai, Inc. the leading applied artificial intelligence healthcare company, is excited to announce the expansion of Viz RECRUIT, Viz’s Clinical Trial Platform at the International Stroke Conference in Los Angeles (Feb. 19-21). Viz RECRUIT employs artificial int

Aptinyx Inc. announced that company management will be presenting at the following investor conferences

Nutraceutical International Corporation (“Nutraceutical” or “the Company”) today announced the appointment of Monty Sharma as its new Chief Executive Officer. Sharma was most recently President and CEO of Jenny Craig, a leader in the weight loss and health industry.

Tizona Therapeutics, Inc., a clinical stage, privately held company developing first-in-class cancer immunotherapies, announced today that Scott Clarke, Chief Executive Officer, will present at The Cowen and Company 40th Annual Healthcare Conference on Wednesday, March 4th a

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”) today provided an update on the ZIMHI™ New Drug Application (NDA) resubmission process.